These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18162176)

  • 1. The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.
    Juncadella IJ; Garg R; Bates TC; Olivera ER; Anguita J
    Biochem Biophys Res Commun; 2008 Feb; 367(1):41-6. PubMed ID: 18162176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15.
    Juncadella IJ; Garg R; Ananthnarayanan SK; Yengo CM; Anguita J
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):433-8. PubMed ID: 17343683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15.
    Garg R; Juncadella IJ; Ramamoorthi N; Ashish ; Ananthanarayanan SK; Thomas V; Rincón M; Krueger JK; Fikrig E; Yengo CM; Anguita J
    J Immunol; 2006 Nov; 177(10):6579-83. PubMed ID: 17082567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel Salp15-like immunosuppressant genes from salivary glands of Ixodes persulcatus Schulze tick.
    Mori A; Konnai S; Yamada S; Hidano A; Murase Y; Ito T; Takano A; Kawabata H; Onuma M; Ohashi K
    Insect Mol Biol; 2010 Jun; 19(3):359-65. PubMed ID: 20201978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.
    Anguita J; Ramamoorthi N; Hovius JW; Das S; Thomas V; Persinski R; Conze D; Askenase PW; Rincón M; Kantor FS; Fikrig E
    Immunity; 2002 Jun; 16(6):849-59. PubMed ID: 12121666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
    Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
    Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
    Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
    Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4.
    Wieder KJ; Chatis P; Boltax J; Wieder I; Nuovo G; Strom TB
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):867-76. PubMed ID: 8798971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding.
    el Ahmar W; Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):855-8. PubMed ID: 1720631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressive effect of the tick protein, Salp15, is long-lasting and persists in a murine model of hematopoietic transplant.
    Tomás-Cortázar J; Martín-Ruiz I; Barriales D; Pascual-Itoiz MÁ; de Juan VG; Caro-Maldonado A; Merino N; Marina A; Blanco FJ; Flores JM; Sutherland JD; Barrio R; Rojas A; Martínez-Chantar ML; Carracedo A; Simó C; García-Cañas V; Abecia L; Lavín JL; Aransay AM; Rodríguez H; Anguita J
    Sci Rep; 2017 Sep; 7(1):10740. PubMed ID: 28878331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein.
    Brodsky MH; Warton M; Myers RM; Littman DR
    J Immunol; 1990 Apr; 144(8):3078-86. PubMed ID: 1691226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
    Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
    J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant CD4 molecules with improved binding to HIV envelope protein gp120 selected by phage display.
    Krykbaev R; McKeating J; Jones I
    Virology; 1997 Aug; 234(2):196-202. PubMed ID: 9268150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
    Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
    J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function.
    Repke H; Gabuzda D; Palù G; Emmrich F; Sodroski J
    J Immunol; 1992 Sep; 149(5):1809-16. PubMed ID: 1354681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.